Effects of Cold Atmospheric Plasma (CAP) on Peritoneal Tumor Tissue

Recruiting N/A Interventional Study
Cold Atmospheric Plasma (CAP) J-Plasma Peritoneal Tumor
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
5 (estimated)
Sponsor
University Hospital, Ghent · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

There are to date no studies available that have examined the effects of CAP on tumor tissue in patients. The aim of this study is to investigate these effects in patients undergoing surgery for peritoneal metastases. Tumor nodules will be treated with different durations and intensities of CAP before being surgically removed. The resected nodules will be analyzed for tumor vitality.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: * Patients with peritoneal metastases undergoing surgery (CRS, debulking), irrespective of the origin. Potential cancer types include ovarian cancer, colorectal cancer, and malignant peritoneal mesothelioma * Written informed consent * Age ≥ 18 years.
Contacts

Wim Ceelen, professor

+3293326251

wim.ceelen@ugent.be

CONTACT

Sarah Cosyns, doctor

+3293321562

sarah.cosyns@ugent.be

CONTACT